Atlas Trials

C4 Therapeutics, Inc.

5 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch C4 Therapeutics, Inc.

RecordFirmDate
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma (NCT07284758)C4 Therapeutics, Inc.2026-02-18
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects (NCT07280013)C4 Therapeutics, Inc.2026-02-06
A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 as Monotherapy and Combination Therapy in Subjects With BRAF V600 Mutant Solid Tumors (NCT05668585)C4 Therapeutics, Inc.2022-12-08
A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors (NCT05355753)C4 Therapeutics, Inc.2022-03-25
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma (NCT04756726)C4 Therapeutics, Inc.2021-04-27

Track C4 Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.